J. Craig Venter

Do you believe that biological production of hydrogen will exist someday?File PhotoMolecular biologist J. Craig Venter is a scientist whose status transcends his own circle. Within the last year, Venter has been interviewed or mentioned in dozens of newspaper stories. His bold, singular scientific adventures generate comment and criticism, and his direct, conversational approach sounds more plebian than patrician. He's not a man who readily bows to barriers, a quality the press finds irresistibl

Written byChristine Bahls
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

File Photo

Molecular biologist J. Craig Venter is a scientist whose status transcends his own circle. Within the last year, Venter has been interviewed or mentioned in dozens of newspaper stories. His bold, singular scientific adventures generate comment and criticism, and his direct, conversational approach sounds more plebian than patrician. He's not a man who readily bows to barriers, a quality the press finds irresistible.

Venter, 57, who introduced whole-genome shotgun sequencing and expressed sequence tags (ESTs) to the world, was a born scrapper. One of six children, Venter says he grew up in a household where amenities were few. Often in trouble at home and school, it was the witnessed horrors of Vietnam, where he served as a corpsman, which propelled him toward his future. "I have an attitude and intelligence," he says. "I was destined to make breakthroughs, or end up in trouble. There is seldom middle ground ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies